PULMONARY SARCOIDOSIS
Clinical trials for PULMONARY SARCOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new PULMONARY SARCOIDOSIS trials appear
Sign up with your email to follow new studies for PULMONARY SARCOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to calm lung inflammation in sarcoidosis
Disease control Recruiting nowThis study tests an oral drug called OATD-01 for people with active pulmonary sarcoidosis, a condition causing lung inflammation. About 96 adults will receive either the drug or a placebo for 12 weeks. The goal is to see if the drug reduces inflammation in the lungs, measured by …
Matched conditions: PULMONARY SARCOIDOSIS
Phase: PHASE2 • Sponsor: Molecure S.A. • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
New drug could help sarcoidosis patients cut steroids
Disease control Recruiting nowThis study tests a new medicine called XTMAB-16 for people with lung sarcoidosis, a condition that causes inflammation and can make breathing hard. The goal is to see if the drug is safe and can help patients reduce their use of steroids, which often have side effects. About 94 a…
Matched conditions: PULMONARY SARCOIDOSIS
Phase: PHASE1, PHASE2 • Sponsor: Xentria, Inc. • Aim: Disease control
Last updated May 26, 2026 12:03 UTC
-
Scientists hunt for lung disease genes in 3,500 volunteers
Knowledge-focused Recruiting nowThis study looks at how genes play a role in lung diseases like cystic fibrosis, asthma, and pulmonary fibrosis. Researchers will study the DNA of up to 3,500 people with and without lung disease to find genetic differences. The goal is to better understand what causes these dise…
Matched conditions: PULMONARY SARCOIDOSIS
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 26, 2026 10:35 UTC